Literature DB >> 27997040

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.

J K Hicks1, K Sangkuhl2, J J Swen3, V L Ellingrod4, D J Müller5, K Shimoda6, J R Bishop7, E D Kharasch8, T C Skaar9, A Gaedigk10, H M Dunnenberger11, T E Klein2, K E Caudle12, J C Stingl13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27997040      PMCID： PMC5478479          DOI： 10.1002/cpt.597

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  34 in total

1.  Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients.

Authors:  A de Vos; J van der Weide; H M Loovers
Journal:  Pharmacogenomics J       Date:  2010-06-08       Impact factor: 3.550

2.  A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.

Authors:  Sarah C Sim; Carl Risinger; Marja-Liisa Dahl; Eleni Aklillu; Magnus Christensen; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

3.  10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes.

Authors:  P Dalén; M L Dahl; M L Bernal Ruiz; J Nordin; L Bertilsson
Journal:  Clin Pharmacol Ther       Date:  1998-04       Impact factor: 6.875

Review 4.  The treatment of neuropathic pain: antidepressants and opioids.

Authors:  C P Watson
Journal:  Clin J Pain       Date:  2000-06       Impact factor: 3.442

Review 5.  The emerging role of cytochrome P450 3A in psychopharmacology.

Authors:  T A Ketter; D A Flockhart; R M Post; K Denicoff; P J Pazzaglia; L B Marangell; M S George; A M Callahan
Journal:  J Clin Psychopharmacol       Date:  1995-12       Impact factor: 3.153

6.  The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population.

Authors:  Jónrit Halling; Pál Weihe; Kim Brosen
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

7.  The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.

Authors:  R G Cooke; J J Warsh; H C Stancer; K L Reed; E Persad
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

8.  Steady-state kinetics of fluoxetine and amitriptyline in patients treated with a combination of these drugs as compared with those treated with amitriptyline alone.

Authors:  A el-Yazigi; K Chaleby; A Gad; D A Raines
Journal:  J Clin Pharmacol       Date:  1995-01       Impact factor: 3.126

9.  Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study.

Authors:  Chiaki Kawanishi; Stefan Lundgren; Hans Agren; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2003-12-02       Impact factor: 2.953

10.  Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.

Authors:  W Z Potter; A P Zavadil; I J Kopin; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1980-03
View more
  141 in total

1.  Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.

Authors:  Rachel Huddart; Alison E Fohner; Michelle Whirl-Carrillo; Genevieve L Wojcik; Christopher R Gignoux; Alice B Popejoy; Carlos D Bustamante; Russ B Altman; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2019-01-21       Impact factor: 6.875

Review 2.  Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.

Authors:  Jacob T Brown; Jeffrey R Bishop; Katrin Sangkuhl; Erika L Nurmi; Daniel J Mueller; Jean C Dinh; Andrea Gaedigk; Teri E Klein; Kelly E Caudle; James T McCracken; Jose de Leon; J Steven Leeder
Journal:  Clin Pharmacol Ther       Date:  2019-04-13       Impact factor: 6.875

Review 3.  Moving pharmacoepigenetics tools for depression toward clinical use.

Authors:  Laura M Hack; Gabriel R Fries; Harris A Eyre; Chad A Bousman; Ajeet B Singh; Joao Quevedo; Vineeth P John; Bernhard T Baune; Boadie W Dunlop
Journal:  J Affect Disord       Date:  2019-02-06       Impact factor: 4.839

Review 4.  Value of Supportive Care Pharmacogenomics in Oncology Practice.

Authors:  Jai N Patel; Lauren A Wiebe; Henry M Dunnenberger; Howard L McLeod
Journal:  Oncologist       Date:  2018-04-05

5.  Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.

Authors:  Wanqiong Qiao; Suparna Martis; Geetu Mendiratta; Lisong Shi; Mariana R Botton; Yao Yang; Andrea Gaedigk; Raymon Vijzelaar; Lisa Edelmann; Ruth Kornreich; Robert J Desnick; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2018-12-06       Impact factor: 2.533

Review 6.  Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.

Authors:  Yao Yang; Mariana R Botton; Erick R Scott; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2017-05-04       Impact factor: 2.533

7.  CYP2D6 allele frequencies, copy number variants, and tandems in the population of Hong Kong.

Authors:  Wing Chan; Man S Li; Senthil K Sundaram; Brian Tomlinson; Pik Y Cheung; Chi H Tzang
Journal:  J Clin Lab Anal       Date:  2018-08-01       Impact factor: 2.352

Review 8.  Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Authors:  Roxana Daneshjou; Rachel Huddart; Teri E Klein; Russ B Altman
Journal:  Semin Cutan Med Surg       Date:  2019-03-01

9.  How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.

Authors:  Richard J Marrero; Emily J Cicali; Meghan J Arwood; Elizabeth Eddy; David DeRemer; Brian H Ramnaraign; Karen C Daily; Dennie Jones; Kelsey J Cook; Larisa H Cavallari; Kristin Wiisanen Weitzel; Taimour Langaee; Kimberly J Newsom; Petr Starostik; Michael J Clare-Salzer; Julie A Johnson; Thomas J George; Rhonda M Cooper-DeHoff
Journal:  Clin Pharmacol Ther       Date:  2020-07-06       Impact factor: 6.875

Review 10.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.